The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences

Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination

(2017) Michael Kongsgaard et al.   Scientific Reports

Yellow fever vaccine: worthy friend or stealthy foe?

(2016) Stephen J. Seligman et al.   Expert Review of Vaccines

Fractional dosing of yellow fever vaccine to extend supply: a modelling study

(2016) Joseph T Wu et al.   LANCET

Yellow fever vaccine-associated viscerotropic disease: current perspectives

(2016) Roger Thomas   Drug Design Development and Therapy

The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells

(2016) Alan M. Watson et al.   PLoS Pathogens

Safety and immunogenicity of inactivated poliovirus vaccine when given with measles–rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia

(2016) Ed Clarke et al.   Lancet Global Health

A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination

(2016) Rosanne W. Wieten et al.   PLoS One

Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine

(2015) Huabin Liang et al.   Cellular & Molecular Immunology

Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali

(2015) Panchali Roy Chowdhury et al.   CLINICAL INFECTIOUS DISEASES

Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans

(2015) Axel Ronald Schulz et al.   JOURNAL OF IMMUNOLOGY

A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old

(2015)   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination

(2015) Rama S. Akondy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures

(2015) Renata C. Pereira et al.   VACCINE

Serious adverse events associated with yellow fever vaccine

(2015) Reinaldo de Menezes Martins et al.   Human Vaccines & Immunotherapeutics

Booster dose after 10 years is recommended following 17DD-YF primary vaccination

(2015) Ana Carolina Campi-Azevedo et al.   Human Vaccines & Immunotherapeutics

A DNA Vaccine against Yellow Fever Virus: Development and Evaluation

(2015) Milton Maciel et al.   PLoS Neglected Tropical Diseases

Seroconversion in Patients With Rheumatic Diseases Treated With Immunomodulators or Immunosuppressants, Who Were Inadvertently Revaccinated Against Yellow Fever

(2015) Ana C. V. Oliveira et al.   Arthritis & Rheumatology

Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline

(2014) Ana Carolina Campi-Azevedo et al.   BMC INFECTIOUS DISEASES

Immune activation alters cellular and humoral responses to yellow fever 17D vaccine

(2014) Enoch Muyanja et al.   JOURNAL OF CLINICAL INVESTIGATION

Yellow Fever Outbreaks in Unvaccinated Populations, Brazil, 2008–2009

(2014) Alessandro Pecego Martins Romano et al.   PLoS Neglected Tropical Diseases

Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years

(2013) Eduardo Gotuzzo et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Immunity to viruses: learning from successful human vaccines

(2013) Bali Pulendran et al.   IMMUNOLOGICAL REVIEWS

Temporal Dynamics of the Primary Human T Cell Response to Yellow Fever Virus 17D As It Matures from an Effector- to a Memory-Type Response

(2013) K. Blom et al.   JOURNAL OF IMMUNOLOGY

Yellow Fever Vaccination Elicits Broad Functional CD4+T Cell Responses That Recognize Structural and Nonstructural Proteins

(2013) Eddie A. James et al.   JOURNAL OF VIROLOGY

Early IFN-Gamma Production after YF 17D Vaccine Virus Immunization in Mice and Its Association with Adaptive Immune Responses

(2013) Patrícia C. C. Neves et al.   PLoS One

Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more

(2013) Karina Takesaki Miyaji et al.   Human Vaccines & Immunotherapeutics

17DD yellow fever vaccine

(2013) Reinaldo M. Martins et al.   Human Vaccines & Immunotherapeutics

Dissection of Antibody Specificities Induced by Yellow Fever Vaccination

(2013) Oksana Vratskikh et al.   PLoS Pathogens

The Safety of Yellow Fever Vaccine 17D or 17DD in Children, Pregnant Women, HIV+ Individuals, and Older Persons: Systematic Review

(2012) Roger E. Thomas et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Detection of Anti-Yellow Fever Virus Immunoglobulin M Antibodies at 3–4 Years Following Yellow Fever Vaccination

(2012) Katherine B. Gibney et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

The early cellular signatures of protective immunity induced by live viral vaccination

(2012) Siegfried Kohler et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Review of the risks and benefits of yellow fever vaccination including some new analyses

(2012) Thomas P Monath   Expert Review of Vaccines

Plasma HIV-RNA Is the Key Determinant of Long-Term Antibody Persistence After Yellow Fever Immunization in a Cohort of 364 HIV-Infected Patients

(2012) Jérôme Pacanowski et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

17DD and 17D-213/77 Yellow Fever Substrains Trigger a Balanced Cytokine Profile in Primary Vaccinated Children

(2012) Ana Carolina Campi-Azevedo et al.   PLoS One

Description of a Prospective 17DD Yellow Fever Vaccine Cohort in Recife, Brazil

(2011) Andréa Barbosa de Melo et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

CXCR3 in T cell function

(2011) Joanna R. Groom et al.   EXPERIMENTAL CELL RESEARCH

Insights into human CD8+ T-cell memory using the yellow fever and smallpox vaccines

(2011) Rafi Ahmed et al.   IMMUNOLOGY AND CELL BIOLOGY

Cytokine Signatures of Innate and Adaptive Immunity in 17DD Yellow Fever Vaccinated Children and Its Association With the Level of Neutralizing Antibody

(2011) M. Luiza-Silva et al.   JOURNAL OF INFECTIOUS DISEASES

An Inactivated Cell-Culture Vaccine against Yellow Fever

(2011) Thomas P. Monath et al.   NEW ENGLAND JOURNAL OF MEDICINE

Elderly Subjects Have a Delayed Antibody Response and Prolonged Viraemia following Yellow Fever Vaccination: A Prospective Controlled Cohort Study

(2011) Anna H. Roukens et al.   PLoS One

Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study

(2011) L.S. Azevedo et al.   Transplant Infectious Disease

Yellow Fever: A Reemerging Threat

(2010) Christina L. Gardner et al.   CLINICS IN LABORATORY MEDICINE

CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5–7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses

(2010) Patrícia C.C. Neves et al.   VACCINE

Is it time for a new yellow fever vaccine?

(2010) Edward B. Hayes   VACCINE

Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity

(2010) Thomas P. Monath et al.   VACCINE

Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults

(2010) Maria Luiza Silva et al.   VACCINE

Clinical and Immunological Insights on Severe, Adverse Neurotropic and Viscerotropic Disease following 17D Yellow Fever Vaccination

(2009) M. L. Silva et al.   Clinical and Vaccine Immunology

Pathways of memory CD8+ T-cell development

(2009) Oliver Bannard et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response

(2009) R. S. Akondy et al.   JOURNAL OF IMMUNOLOGY

TLR expression and NK cell activation after human yellow fever vaccination

(2009) Patrícia Cristina da Costa Neves et al.   VACCINE

Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development

(2008) Theodore C. Pierson et al.   Cell Host & Microbe

Yellow Fever: 100 Years of Discovery

(2008) J. Erin Staples   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

(2008) Denis Gaucher et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Case of Yellow Fever Vaccine–Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES Genes

(2008) Bali Pulendran et al.   JOURNAL OF INFECTIOUS DISEASES

Pressure-inactivated yellow fever 17DD virus: Implications for vaccine development

(2008) Luciane P. Gaspar et al.   JOURNAL OF VIROLOGICAL METHODS

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

(2008) Troy D Querec et al.   NATURE IMMUNOLOGY

Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination

(2008) Marina Ângela Martins et al.   VACCINE